GET THE APP

..

Journal of Bioengineering & Biomedical Science

ISSN: 2155-9538

Open Access

Drug Development in the Age of Biotechnology: Integrating Science and Technology

Abstract

Yuhua Zhang*

The convergence of biotechnology and pharmaceutical sciences has ushered in a new era of drug development, revolutionizing the way we approach the discovery, design, and delivery of medications. Biotechnology, with its profound understanding of living organisms and their molecular processes, has become a driving force behind the development of innovative therapeutics. This paper explores the impact of biotechnology on drug development, focusing on the integration of cutting-edge science and technology to address complex medical challenges. From recombinant DNA technology and monoclonal antibodies to gene therapies and personalized medicine, biotechnology-driven drug development has opened doors to targeted, precise, and patient-centric treatments. This paper delves into the advancements in biotechnology, the challenges faced in this domain, and the potential future directions that hold promise for transforming healthcare through novel drug therapies.

HTML PDF

Share this article

Google Scholar citation report
Citations: 307

Journal of Bioengineering & Biomedical Science received 307 citations as per Google Scholar report

Journal of Bioengineering & Biomedical Science peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward